Schonfeld Strategic Advisors »

Kalvista Pharmaceuticals shares owned by Schonfeld Strategic Advisors

Quarter-by-quarter ownership of Kalvista Pharmaceuticals (KALV) shares owned by Schonfeld Strategic Advisors from 13F filings

Historical chart of Schonfeld Strategic Advisors investment in Kalvista Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Kalvista Pharmaceuticals held by Schonfeld Strategic Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kalvista Pharmaceuticals by Schonfeld Strategic Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $4.9M 306k 16.15
2025-09-30 $5.4M 446k 12.18
2025-06-30 $1.6M 145k 11.31
2025-03-31 $6.7M 582k 11.54
2024-03-31 $152k 13k 11.86
2019-09-30 $471k 41k 11.60
2019-06-30 $2.4M 106k 22.15
2019-03-31 $315k 11k 28.64

More positions owned by Schonfeld Strategic Advisors

Ishares Tr Core S&p500 Etf (IVV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
NVIDIA Corporation (NVDA)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Ishares Tr China Lg-cap Etf (FXI)
Microsoft Corporation (MSFT)
Tesla Motors (TSLA)
Amazon (AMZN)
Alphabet Cap Stk Cl C (GOOG)
Ishares Silver Tr Ishares (SLV)
Alphabet Cap Stk Cl A (GOOGL)
Fidelity Wise Origin Bitcoin SHS (FBTC)
Ishares Ethereum Tr SHS (ETHA)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Spdr Series Trust State Street Spd Call Option (KRE)

View all positions for Schonfeld Strategic Advisors

Top funds holding Kalvista Pharmaceuticals

VR Adviser
Frazier Life Sciences Management
Suvretta Capital Management
Tang Capital Management
BlackRock
Capital World Investors
Vanguard Group
Silverarc Capital Management
Point72 Asset Management
Millennium Management
Woodline Partners
State Street Corporation
Vestal Point Capital
Kynam Capital Management
Parkman Healthcare Partners

View all funds holding Kalvista Pharmaceuticals